Healthcare101

 The global injectable drug delivery market continues to experience strong momentum, supported by rising chronic disease prevalence, expanding biologics pipelines, and rapid advancements in self-injection technologies. With regional CAGR figures showing steady growth — Europe (7.7%), APAC (9.8%), MEA (6.5%), and North America (8.3%) — the market is undergoing a significant transformation driven by innovation, patient-centric delivery systems, and strategic partnerships among leading pharmaceutical players. From wearable injectors to needle-free systems, the landscape of injectable drug delivery is evolving to improve patient compliance, safety, and therapeutic outcomes. Below is a comprehensive analysis of the latest market dynamics, opportunities, challenges, and key industry developments shaping this space. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=150 Market Dynamics Driving the Future of Injectable Drug Delivery 1. Driver: Risin...

The global MRI systems market , valued at US$6.15 billion in 2024 , grew to US$6.56 billion in 2025 and is projected to advance at a CAGR of 6.5% from 2025 to 2030 , reaching US$9.01 billion by 2030 . This growth reflects the increasing demand for advanced diagnostic imaging solutions as the burden of neurological, musculoskeletal, and chronic diseases continues to rise worldwide. With an aging global population and the rising prevalence of conditions such as cancer , Alzheimer’s, Parkinson’s disease, and spinal disorders, MRI systems are playing a pivotal role in non-invasive disease diagnosis and management. Additionally, regulatory support for innovation, favorable reimbursement policies, and technological advancements are further propelling the market forward. Download PDF Brochure: Attractive Opportunities in the MRI Systems Market North America Dominance North America holds the largest share of the global MRI systems market. This dominance is driven by: A la...

 The global pharmaceutical contract manufacturing market continues its upward trajectory, driven by increasing outsourcing demand, rapid biologics expansion, and the push for cost-efficient, flexible production models. Valued at US$193.52 billion in 2024 , the market rose to US$209.90 billion in 2025 and is projected to reach US$311.95 billion by 2030 , advancing at a robust CAGR of 8.2% during the forecast period. As pharmaceutical manufacturers navigate complex global supply chains, evolving regulatory expectations, and accelerated drug development cycles, contract manufacturing organizations (CMOs/CDMOs) are emerging as essential partners for scalability, innovation, and operational resilience. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201524381 Why Contract Manufacturing Is Becoming a Cornerstone of Pharma Strategy The shift toward outsourcing is no longer solely cost-driven; it is increasingly rooted in strategic value creati...

 The AI in clinical trials market refers to the utilization of artificial intelligence-based tools to improve the different phases as well as steps of clinical research process activity such as trial development, enrolment of patients, data management and analysis and therapeutic monitoring. Al assists in accomplishing such tasks by automating the collection of data, enhancing the efficiency of patient matching and improving prediction of outcomes of trials which in turn helps in reducing the timeline and cost associated with these processes. Market Overview The integration of Artificial Intelligence (AI) into clinical trials is revolutionizing the drug development process. AI offers the potential to accelerate timelines, reduce costs, and improve the overall efficiency and accuracy of clinical research. From patient recruitment and data analysis to predictive modeling and risk assessment, AI is transforming various aspects of clinical trials. Market Size and Forecast 2023 Market ...

  Market Overview Pharmacogenomics , the study of how genes affect a person's response to drugs, is revolutionizing healthcare by enabling personalized medicine. By analyzing an individual's genetic makeup, healthcare professionals can predict how they will respond to specific medications, optimizing treatment efficacy and minimizing adverse drug reactions. This approach is particularly valuable in areas such as oncology, cardiology, and neurology, where drug responses can vary significantly among patients. Market Size and Growth The global pharmacogenomics market has experienced steady growth in recent years, driven by increasing awareness of the benefits of personalized medicine, technological advancements in genetic testing, and rising healthcare expenditure. The market was valued at US$3.3 billion in 2022 and US$3.5 billion in 2023. The projected CAGR of 10.6% from 2023 to 2028 indicates a strong growth trajectory, with the market expected to reach US$5.8 billion by 2...

  Market Overview The North American laboratory informatics market is expected to be worth USD 3.5 billion by 2029, growing at a CAGR of 10.7% during the forecast period. Laboratory informatics encompasses a range of software and data management tools used to optimize laboratory operations, improve data quality, and ensure regulatory compliance. These tools include Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELNs), Chromatography Data Systems (CDS), and Scientific Data Management Systems (SDMS). The North American market is characterized by a high level of technological adoption, a strong regulatory environment, and a significant presence of pharmaceutical, biotechnology, and research institutions. Download PDF Brochure Key Drivers Several factors are contributing to the growth of the laboratory informatics market in North America: Increasing Adoption of Automation: Laboratories are increasingly adopting automation technolog...

  Market Overview Apheresis is a medical procedure in which blood is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. It is used therapeutically to remove harmful substances from the blood or to collect specific blood components for transfusion or further processing. The North American apheresis market encompasses the sales of apheresis devices, disposables, and related services within the United States, Canada, and Mexico. Market Size and Growth The North American apheresis market is substantial and is characterized by consistent growth. The market size is currently significant, and projections indicate a robust expansion over the forecast period. Key Statistics: Projected Market Size by 2029: USD 1.7 billion Compound Annual Growth Rate (CAGR): 8.4% (2024-2029) Download PDF Brochure This growth is driven by a confluence of factors, including: Increasing Prevalence of Tar...